Human Research Protection Program
IRB Administration
Administered through the Ογ½ΆΦ±²₯ Research Integrity office, Ογ½ΆΦ±²₯ IRBs review research involving human subjects. All human research studies are reviewed by the IRB before they begin and throughout the project to evaluate risks to subjects and compliance with federal regulations and institutional policies.
Ογ½ΆΦ±²₯ has a Federal-Wide Assurance (FWA) # 00006767 with the Department of Health and Human Services to protect the rights and welfare of participants involved in research affiliated with this institution.
Two Ογ½ΆΦ±²₯ IRBs serve six campuses. For contact information, board membership, and submission deadlines select your campus below.
IMPORTANT NOTICE REGARDING PI CVsALL PIs need to have a current, up-to-date, signed and dated curriculum vitae in the IRB records (per the IRB manual section 3.18.1). |
Lubbock IRB
(serves Lubbock campus)
(IRB # 1 - 00000096)
Amarillo IRB
(serves Amarillo, Abilene, Dallas, and Permian Basin campuses, and ASU)
(IRB # 2 - 00000097)
Ογ½ΆΦ±²₯ Investigators
CLICK HERE to go directly to the HRPP Education and Training page.
Jennifer Board
Research COI & CMP Chief Analyst
806.414.9934
jennifer.board@ttuhsc.edu
When Ογ½ΆΦ±²₯ researchers conduct research at other institutions, Ογ½ΆΦ±²₯ must enter into a formal written agreement with the other institution to define the responsibilities of each entity. No research may begin until an agreement has been formally executed and the designated IRB has approved the project.
The following institutions have established agreements with Ογ½ΆΦ±²₯ that allow the Ογ½ΆΦ±²₯ IRBs to review and provide continuing oversight of human research conducted by Ογ½ΆΦ±²₯ faculty (CLICK HERE for the list). These agreements define the parameters for Ογ½ΆΦ±²₯ IRB review, including the conditions under which the review will be considered, each institution's responsibilities and financial commitments.
Institutions for which the Ογ½ΆΦ±²₯ IRB is the IRB of record may reserve the regulatory right (FDA 21 CFR 56.12, DHHS 45 CFR 46.112) to exercise institutional disapproval of research the Board has approved, but may not approve research that has been disapproved by a Ογ½ΆΦ±²₯ IRB serving as the IRB of record.
MORE
Click HERE to be directed to the HRPP Manual.
Summary of Changes for September 2024 Version
Click HERE for a PDF of the flowchart.
Click HERE for information on Laboratory Inspections and Violations.
For additional information, please contact Safety Services or the IBC Office.
Links
- Ογ½ΆΦ±²₯ Related Links
- Federal Regulations & Guidelines
- Resources for Research Participants
- Compliance
Documents (PDFs)
- FWA
- Ογ½ΆΦ±²₯ Co-Operative IRB Agreements
- Procedure for Determining the Use of an External IRB
- Checklist for Evaluating Whether a Clinical Trial is an Applicable Clinical Trial
- Registering with ClinicalTrials.gov
Frequently Asked Questions (FAQs)
Cayuse Training Videos
Overviews
Quick Tips
User Guides (PDF)
Links
Resource Information
to access all Consent Forms.
You will need to login with your eRaider credentials.
Cayuse Access Links |
iRIS ACCESS(for read-only access) |
Questions or Comments? |
|
Contact us at |
HRPP Manual(Human Research Protection Program)
Summary of Changes for September 2024 Version |
IRB Review Process Flowchart |
Cayuse Human Ethics Platform (for IRB Submissions)
|